Company: SMNR
Filing Date: 2025-04-21
Form Type: CORRESP
Source: 0001193125-25-087365
Chunk: 12

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: CORRESP
Chunk 12
---
 the written consent of Syneos Health as an exhibit to the registration statement. Refer to Section 7 of the Securities Act and Securities Act Rule 436. |

Response: The Company respectfully submits that Syneos Health is not an “expert” under Rule 436 of the Securities Act of 1933, as amended (the “ Securities Act”). Rule 436 of the Securities Act requires that a consent be filed if any portion of a report or opinion of an “expert” is quoted or summarized as such in a registration statement. Section 7 of the Securities Act provides that an expert is “any accountant, engineer, or appraiser, or any person whose profession gives authority to a statement made by him.” The Company respectfully submits that Syneos Health, a biopharmaceutical solutions organization providing contract research services, is not among the class of persons subject to Section 7 and Rule 436 of the Securities Act as “experts” unless the Company expressly identifies such provider as an “expert” or the statements are purported to be made on the authority of such provider as an “expert”. The Company has neither expressly identified Syneos Health as an “expert” in the Registration Statement nor purported to make statements in the Registration Statement on the authority of Syneos Health as an “expert”. In addition, the Company’s references to Syneos Health are not intended to convey that such information was “expertized,” but rather are intended to convey information that the Company used to assess various market opportunities, strategies, estimated growth rate and price per unit as part of the Company’s broader development and commercialization plans for SP-102.Accordingly, the Company believes Syneos Health should not be considered an “expert” within the meaning of U.S. federal securities laws. 11

U.S. Securities and Exchange Commission April 21, 2025 In addition, pursuant to the Staff’s guidance contained in Question 233.02 of Securities Act Rules Compliance and Disclosure Interpretations, “[t]he registrant has no requirement to make reference to a third-party expert simply because the registrant used or relied on the third-party expert’s report or valuation or opinion in connection with the preparation of a Securities Act registration statement”. It further provides that “[i]f the registrant determines to make reference to a third-party expert, the disclosure should make clear whether any related statement included or incorporated in a registration statement is a statement of the third-party expert or a statement of the registrant.” The Company acknowledges the Staff’s comment